NCT04451083View on ClinicalTrials.gov

Multiple-dose Study of FOY-305 in Japanese Healthy Adult Male Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

July 1, 2020

Primary Completion Date

August 17, 2020

Study Completion Date

August 17, 2020

Conditions
Healthy Volunteers
Interventions
DRUG

FOY-305

Multiple-dose of FOY-305 will be administered orally at 4 times/day.

Trial Locations (1)

812-0025

Fukuoka Clinical Site 01, Fukuoka

Sponsors
All Listed Sponsors
lead

Ono Pharmaceutical Co. Ltd

INDUSTRY